Proposed Maximum Aggregate Value of Transaction | Fee Rate | Amount of Filing Fee | ||||
| $ | | $ | |||
Fees Previously Paid | — | — | ||||
Total Transaction Valuation | $ | |||||
Total Fees Due for Filing | $ | |||||
Total Fees Previously Paid | | |||||
Total Fee Offsets | | |||||
Net Fee Due | $ |
i.
|
51,069,793 issued and outstanding shares of Common Stock, as of March 31, 2025, multiplied by $25.00 per share;
|
ii.
|
837,143 shares of Common Stock underlying Company RSUs,
as of March 31, 2025, multiplied by
$25.00 per share;
|
iii.
|
an estimated maximum amount of 113,479 shares of Common Stock underlying Company RSUs that may be granted under a Company Stock
Plan prior to the closing of the transaction and entitled to the Per Share Merger Consideration, multiplied by $25.00 per share
|
iv.
|
an estimated maximum amount 614,164 shares of Common Stock underlying Company Performance Shares, as of March 31, 2025, multiplied by $25.00 per share;
|
v.
|
an estimated maximum amount of 53,978 shares of Common Stock underlying Company Performance Shares that may be granted under a
Company Stock Plan prior to the closing of the transaction and entitled to the Per Share Merger Consideration, multiplied by $25.00 per share.
|
vi.
|
222,090 shares of Common Stock underlying Company Deferred Shares, as of March 31, 2025, multiplied by $25.00 per share;
|
vii.
|
an estimated maximum amount of 104,320 shares of Common Stock underlying Company Deferred Shares that may be granted under the Company
Director Deferred Stock Compensation Plan prior to the closing of the transaction and entitled to the Per Share Merger Consideration, multiplied by $25.00
per share.
|